Harmony Biosciences
HRMY
HRMY
204 hedge funds and large institutions have $1.62B invested in Harmony Biosciences in 2023 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
204
Holders Change
-6
Holders Change %
-2.86%
% of All Funds
3.25%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
32
Increased
86
Reduced
56
Closed
38
Calls
$9.47M
Puts
$4.32M
Net Calls
+$5.15M
Net Calls Change
+$9.91M
Top Buyers
| 1 |
BlackRock
New York
|
$201M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$46.5M |
| 3 |
PA
Perceptive Advisors
New York
|
$32.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$121M |
| 5 |
State Street
Boston,
Massachusetts
|
$40.2M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$7.93M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
$7.5K |
| 3 |
Millennium Management
New York
|
$3.46M |
| 4 |
Man Group
London,
United Kingdom
|
$3.25M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
$6.74M |
